 SILVER SPRING, Md., Feb. 11, 2021 GLOBE NEWSWIRE -- Aziyo Biologics, Inc. Nasdaq: AZYO, a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today product design completion for CanGaroo with antibiotics, the next generation of the Companys CanGaroo Envelope. 